Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-18, Stock:NVS, The news for the past five days is as follows:
2019-11-11: NEWS1: Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day.NEWS2: The Zacks Analyst Blog Highlights: Novo Nordisk, Allergan, Sanofi, Novartis and J&J.NEWS3: Novartis' Generics Unit to Buy Aspen's Japanese Operations.NEWS4: Novartis buys Aspen's Japanese generic unit for up to 400 million euros.NEWS5: UPDATE 1-Roche sets sights on Novartis, Biogen as SMA trial hits target.
2019-11-12: NEWS1: Roche's SMA Drug Meets Primary Endpoint in Pivotal Study.
2019-11-13: NEWS1: Ex-Novartis exec named as Flagship's ‘matchmaker’ for Big Pharma partnerships.NEWS2: Top Analyst Reports for Microsoft, Novartis & Novo Nordisk.
2019-11-14: NEWS1: Sarepta expands gene therapy push with $90M deal.NEWS2: The Zacks Analyst Blog Highlights: Microsoft, Novartis, Novo Nordisk, Tesla and General Dynamics.
2019-11-15: NEWS1: Novartis sickle-cell drug gets U.S. FDA approval.NEWS2: CORRECTED-UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval.NEWS3: Drug giant Roche acquires Lexington biotech for $390M.

Answer: Rise